Could YouTubeTM encourage men on prostate checks?  A contemporary analysis

Morra, Simone; Napolitano, Luigi; Ruvolo, Claudia Collà; Celentano, Giuseppe; Rocca, Roberto La; Capece, Marco; Creta, Massimiliano; Passaro, Francesco; Bello, Francesco Di; Cirillo, Luigi; Turco, Carmine; Mauro, Ernesto Di; Pezone, Gabriele; Fraia, Agostino; Mangiapia, Francesco; Fusco, Ferdinando; Mirone, Vincenzo; Califano, Gianluigi; Longo, Nicola

doi:10.4081/aiua.2022.3.285

Cited by 16 publications

(16 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the complexity of the topic and the involved patients, the Internet and particularly YouTube TM may represent a crucial instrument to improve the communication between physicians and patients [ 53 ]. Indeed, videos could be an effective tool to improve patient awareness thanks to the visual provision of information, which could overcome some health literacy barriers [ 54 ].…”

Section: Discussionmentioning

confidence: 99%

Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background: YouTubeTM is an open-access source for mass information. Several previous studies of YouTubeTM videos showed a high rate of misinformation in the urological field. The aim of the current study was to evaluate the quality of information on immunotherapy (IMT) for urological tumors uploaded to YouTubeTM. Methods: YouTubeTM videos were searched using nine keyword combinations. The PEMAT, the DISCERN tool, and the Misinformation scale were used to assess the quality of information in YouTubeTM videos about IMT for urological tumors. Descriptive statistics and Kruskal–Wallis, Chi-square, proportion, and Pearson’s tests were performed. Results: According to the selection criteria, 156 YouTubeTM videos were suitable for the analysis and stratified according to topic (urothelial carcinoma vs. renal cell cancer vs. prostate cancer vs. general information on IMT). According to PEMAT A/V, the overall Understandability score was 40% (Inter-Quartile Range [IQR]: 20–61.5) and the overall Actionability score was 0% (IQR: 0–25). According to the DISCERN tool, the overall DISCERN score was 44 (IQR: 39–53.2), defined as “fair”. According to the Misinformation scale, we recorded the lowest median overall score for item 4 (“IMT in multimodality approach”) and item 5 (“Future perspective”). Conclusions: YouTubeTM cannot be recommended as a reliable source of information on IMT for urological malignancies. In addition, YouTubeTM videos contributed to the spread of misinformation by underestimating the role of IMT in a multimodality approach and missing the findings of published clinical trial results.

show abstract

Section: Discussionmentioning

confidence: 99%

Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…This review has shown that access to digital technology and connectivity issues are still prominent within rural settings and so investment as well as education is required [ 69 ] to ensure that digital inequalities do not widen as telemedicine models of care continue to be rolled out in a post-pandemic world. People in rural areas may also rely on digital health information provided through social media platforms such as YouTube although the extent to which these provide good quality and reliable information has been questioned by other cancer researchers [ 70 , 71 ].…”

Section: Discussionmentioning

confidence: 99%

A Rapid Systematic Review on the Experiences of Cancer Survivors Residing in Rural Areas during the COVID-19 Pandemic

Nelson

Cooke

McLeod

et al. 2022

IJERPH

View full text Add to dashboard Cite

The COVID-19 pandemic has caused considerable disruption to cancer care and may have exacerbated existing challenges already faced by cancer survivors from rural areas. This has created a need for a rapid evidence synthesis to inform the development of tailored interventions that address the specific needs of rural cancer survivors who continue to be affected by the pandemic. The review was conducted following guidance from the Cochrane Rapid Review Methods Group. Database searches were performed via the EBSCOHost interface (includes MEDLINE, CINAHL, PsycINFO) on 25 May 2022 and supplemented with searches on Google Scholar. Peer-reviewed articles published after March 2020 that reported primary data on the experiences of cancer survivors residing in rural and remote settings during the pandemic were included. Findings were tabulated and written up narratively. Fourteen studies were included. The COVID-19 pandemic had a mostly detrimental impact on the experiences of rural cancer survivors. People’s individual coping mechanisms were challenging for a range of reasons. Specifically, the pandemic impacted on their ability to access testing, treatment, check-ups and supportive care, their ability to maintain and access social support with close friends and family, as well as negative consequences to their finances and emotional wellbeing with some reporting feelings of psychological distress including depression and anxiety. This review provides important insight into the experiences of rural cancer survivors that may help inform tailored support in line with the needs and challenges faced because of the pandemic.

show abstract

“…The highest risk of PCa is in men over 50 years of age or age > 45 years with a family history of PCa [ 3 , 4 , 5 , 6 ]. The diagnosis is made by prostate biopsy in patients with abnormalities detected in their prostate-specific antigen (PSA) levels or digital rectal exam (DRE) [ 7 , 8 , 9 ]. In the last decade, there has been growth in the use of multiparametric magnetic resonance imaging (mpMRI) for the diagnosis and characterization of PCa based on the Prostate Imaging Reporting And Data System (PI-RADS v.2) [ 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

“…According to the European Association of Urology (EAU) guidelines, histological grading of adenocarcinoma of the prostate is based on the definition of the International Society of Urological Pathology (ISUP) or Gleason grade group (GGG) modified grading, defined as ISUP 1 (Gleason score [GS] 6 [3 + 3]), ISUP 2 (GS 7 [3 + 4]), ISUP 3 (GS 7 [4 + 3]), ISUP 4 (GS 8 [4 + 4]) and ISUP 5 (GS 9 or 10) [ 2 , 8 , 9 ]. The GGG is the most important prognostic indicator for PCa [ 12 , 13 , 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background and Objectives: To describe the predictors of cribriform variant status and perineural invasion (PNI) in robot-assisted radical prostatectomy (RARP) histology. To define the rates of upgrading between biopsy specimens and final histology and their possible predictive factors in prostate cancer (PCa) patients undergoing RARP. Material and Methods: Within our institutional database, 265 PCa patients who underwent prostate biopsies and consecutive RARP at our center were enrolled (2018–2022). In the overall population, two independent multivariable logistic regression models (LRMs) predicting the presence of PNI or cribriform variant status at RARP were performed. In low- and intermediate-risk PCa patients according to D’Amico risk classification, three independent multivariable LRMs were fitted to predict upgrading. Results: Of all, 30.9% were low-risk, 18.9% were intermediate-risk and 50.2% were high-risk PCa patients. In the overall population, the rates of the cribriform variant and PNI at RARP were 55.8% and 71.1%, respectively. After multivariable LRMs predicting PNI, total tumor length in biopsy cores (>24 mm [OR: 2.37, p-value = 0.03], relative to <24 mm) was an independent predictor. After multivariable LRMs predicting cribriform variant status, PIRADS (3 [OR:15.37], 4 [OR: 13.57] or 5 [OR: 16.51] relative to PIRADS 2, all p = 0.01) and total tumor length in biopsy cores (>24 mm [OR: 2.47, p = 0.01], relative to <24 mm) were independent predicting factors. In low- and intermediate-risk PCa patients, the rate of upgrading was 74.4% and 78.0%, respectively. After multivariable LRMs predicting upgrading, PIRADS (PIRADS 3 [OR: 7.01], 4 [OR: 16.98] or 5 [OR: 20.96] relative to PIRADS 2, all p = 0.01) was an independent predicting factor. Conclusions: RARP represents a tailored and risk-adapted treatment strategy for PCa patients. The indication of RP progressively migrates to high-risk PCa after a pre-operative assessment. Specifically, the PIRADS score at mpMRI should guide the decision-making process of urologists for PCa patients.

show abstract

Could YouTubeTM encourage men on prostate checks? A contemporary analysis

Cited by 16 publications

References 37 publications

Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

A Rapid Systematic Review on the Experiences of Cancer Survivors Residing in Rural Areas during the COVID-19 Pandemic

Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center

Contact Info

Product

Resources

About